Biopharma Reports Fifth Quarter of Increased Net Revenues
May 15 2023 - 10:40AM
AllPennyStocks.com
Those afflicted with sickle cell disease face many challenges
and acute complications. This biopharma company is the leader in
treatment of the disease and just reported its fifth straight
increase...
To read the full story on AllPennyStocks.com, click
here.
Emmaus Life Sciences (NASDAQ:EMMA)
Historical Stock Chart
From Apr 2024 to May 2024
Emmaus Life Sciences (NASDAQ:EMMA)
Historical Stock Chart
From May 2023 to May 2024